BARCELONA (EGMN) - Locoregional recurrence after breast-conserving therapy remains a very strong, independent risk factor for long-term outcome, even after an extended event-free period.Research presented at the European Breast Cancer Conference showed that, even in women who were event free 10 years after primary treatment, experiencing a locoregional recurrence was the only independent prognostic indicator of worse outcome, as it was associated with both reduced distant disease-free survival and...